Company Performance: Novo Nordisk's financial results, including revenue, earnings, and sales growth, directly impact investor confidence and stock price.

Drug Pipeline & Approvals: Success in developing new drugs and securing regulatory approvals for existing or novel treatments positively influences stock value.

Market Competition: Actions by competitors in the diabetes and obesity care market, such as new product launches or pricing strategies, can affect Novo Nordisk's market share and stock price.

Economic Conditions: Global economic conditions, interest rates, and inflation levels can influence investor sentiment and the overall stock market, impacting NVO.TO.

Regulatory Environment: Changes in healthcare regulations, pricing policies, or drug approval processes in key markets can significantly affect Novo Nordisk's profitability and stock price.

Analyst Ratings & Reports: Investment analysts' ratings, price targets, and research reports can influence investor perception and trading activity, affecting NVO.TO.

Investor Sentiment: General market sentiment, risk appetite, and news events related to the healthcare industry or pharmaceutical sector can impact the demand for Novo Nordisk stock.

Currency Exchange Rates: Fluctuations in exchange rates, particularly between the Danish Krone (DKK) and the Canadian Dollar (CAD), can affect the value of NVO.TO for Canadian investors.

Dividend Policy: Changes in Novo Nordisk's dividend policy can attract or deter investors, influencing the stock price.

Global Health Trends: Growing prevalence of diabetes and obesity worldwide creates market opportunities and impacts investor perceptions of Novo Nordisk's long-term growth potential.